Inventia Healthcare Chlorthalidone Tablet Recall Sparks Concerns Nationwide
Tuesday, 29 September 2026, 23:20

Overview of the Inventia Healthcare Chlorthalidone Tablet Recall
Inventia Healthcare chlorthalidone tablet recall has been announced, affecting patients across the country. This urgent recall highlights significant safety issues associated with a widely prescribed blood pressure medication.
Key Details on the Recall
- Potential Risks: The recalled tablets may not meet the necessary safety standards.
- Dosage Instructions: Patients are advised to consult healthcare professionals regarding alternative medications.
Actions to Take
- Check your medication for the affected batches.
- Contact your healthcare provider for guidance.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.